Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
NICE guidance (NG28) recommends GLP-1 receptor agonists in type 2 diabetes only for specific patients, typically when other treatments have proven insufficient and when certain BMI thresholds are met
In head-to-head trials, tirzepatide improved insulin sensitivity and insulin secretory responses to a greater extent than semaglutide
Ozempic and Mounjaro are FDA-approved to treat diabetes, while Wegovy is an FDA-approved weight loss medication
Match the batch The batch/lot number on the COA should match what's printed on your vial
Ensure you have enough medication to last the duration of your trip and a travel-safe cooling case if needed
WHAT TO EXPECT Consultation: A licensed medical practitioner will assess your health history and determine if GLP-1 therapy may be suitable for you
US$ 27.18
US$ 27.60
US$ 27.62
US$ 26.77
US$ 27.98
US$ 25.06
US$ 28.20
US$ 24.13
